Clinical Trials
10 trialsNCT06627309 2026-03-09
Rapid dFLC Response Predict CHR in AL Amyloidosis
Peking University People's Hospital
Recruiting
NCT07200583 2025-11-18
PAIA-Haplo
Fujian Medical University
Completed
NCT07206810 2025-10-03
A Study of the Bortezomib, Lenalidomide, and Dexamethasone Regimen for the Treatment of Newly Diagnosed Multiple Myeloma Patients
The First Affiliated Hospital of Soochow University
Completed
NCT05163405 2025-08-22
Perspectives of Subcutaneous Velcade at Home of Patients With Myeloma.
Odense University Hospital
Completed
NCT05218603 2022-09-16
Evaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCT
PETHEMA Foundation
Unknown
NCT04678089 2022-04-28
Evaluation of Clinical Treatment of Multiple Myeloma Based on Multi-omics
Beijing Chao Yang Hospital
Unknown
NCT03344328 2020-11-12
PREVIB
University Hospital, Clermont-Ferrand
Completed
NCT02976272 2019-07-01
SENSIB
University Hospital, Clermont-Ferrand
Unknown
NCT02026505 2019-03-13
Evaluation of Cardiotoxic Effects of Bortezomib
Oregon Health and Science University
Completed
NCT02797041 2016-06-14
REBOUND
IRCCS Centro di Riferimento Oncologico della Basilicata
Unknown